Hillsdale Investment Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-296,660
Closed -$6.29M 650
2024
Q3
$6.29M Buy
296,660
+100
+0% +$1.8K 0.48% 44
2024
Q2
$4.69M Sell
296,560
-90,340
-23% -$1.66M 0.37% 71
2024
Q1
$5.75M Sell
386,900
-162,100
-30% -$2.22M 0.46% 43
2023
Q4
$5.02M Sell
549,000
-2,050
-0.4% -$14.1K 0.41% 58
2023
Q3
$3.07M Buy
551,050
+68,050
+14% +$476K 0.28% 139
2023
Q2
$3.89M Buy
+483,000
New +$3.56M 0.36% 117

Other funds holding OSCR

Hillsdale Investment Management's OSCR Position: Q4 2024 in Review

Hillsdale Investment Management sold out of Oscar Health (OSCR) in Q4 2024, closing a stake of 296,660 shares — an estimated $6.29M sold.

Hillsdale Investment Management first reported a position in OSCR in Q2 2023 and held it in 6 quarters. The position peaked at $6.29M in Q3 2024. 263 funds tracked by Wall St. Rank hold OSCR as of Q4 2024.

  • Hillsdale Investment Management reported no remaining Oscar Health position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 296,660 Oscar Health shares in Q4 2024, an estimated $6.29M.
  • Hillsdale Investment Management first reported a position in Oscar Health in Q2 2023 and held it in 6 quarters.
  • Hillsdale Investment Management's Oscar Health position peaked at $6.29M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Oscar Health as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.